DOSE-DEPENDENT ANTI-THROMBOTIC EFFECT OF WARFARIN IN RABBITS
- 1 January 1983
- journal article
- research article
- Vol. 61 (3) , 435-438
Abstract
Rabbits (151), divided into controls and animals treated with varying daily doses of warfarin, were subjected to the stasis assay, and the amount of thrombosis quantitated after intravascular coagulation was initiated either by activated factor X or tissue thromboplastin. Following 8-10 days of warfarin administration, there was a significant dose-dependent decrease in the vitamin-K-dependent coagulation factors paralleled by an increase in the prothrombin time ratio. Whether thrombosis was initiated by activated factor X or tissue thromboplastin, there was, with increasing drug dose, a progressive increase in the inhibition of stasis thrombosis. This significant antithrombotic effect occurred even when the vitamin-K-dependent coagulation activities were at a mean value of 50%.This publication has 8 references indexed in Scilit:
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1982
- ANTI-THROMBOTIC EFFECTS OF WARFARIN AND HEPARIN FOLLOWING INFUSIONS OF TISSUE THROMBOPLASTIN IN RABBITS - CLINICAL IMPLICATIONS1979
- The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction.Circulation Research, 1977
- In vitro and in vivo correlation of clotting protease activity: Effect of heparinProceedings of the National Academy of Sciences, 1977
- BOVINE THROMBIN AND ACTIVATED FACTOR X - SEPARATION AND PURIFICATION1968
- “THROMBOTEST” AND PROTHROMBIN TIME: A CONTROLLED CLINICAL TRIALAustralasian Annals of Medicine, 1965
- Relation of Prothrombin Concentration to Bleeding during Oral Anticoagulant TherapyNew England Journal of Medicine, 1962
- Probability Tables for Individual Comparisons by Ranking MethodsBiometrics, 1947